FDA approves first treatment that delays Type 1 diabetes. Why it could be 'game changing'

Salinas Californian

Nov 18, 2022

A vial of TZIELD costs nearly $14,000, a notable price given the escalating cost of lifesaving insulin for people with diabetes. |!| Salinas